Mette Moustgaard Jeppesen

Mette Moustgaard Jeppesen

Auto-generated profile, based on publicly available information

Mette Moustgaard Jeppesen

Department of Gynaecology and Obstetrics, Odense University Hospital, Odense, Denmark

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2022 in Psycho-Oncology
Verified
Journal Article
Open access
YLYvonne L. Luigjes‐Huizer
Yvonne L. Luigjes‐Huizer
NTNina M. Tauber
Nina M. Tauber
Gerald HumphrisGerald Humphris
Gerald Humphris
NKNadine Kasparian
Nadine Kasparian
WLWendy W. T. Lam
Wendy W. T. Lam
MLMarije L. van der Lee
Marije L. van der Lee
Objective: Care for fear of cancer recurrence (FCR) is considered the most common unmet need among cancer survivors. Yet the prevalence of FCR and predisposing factors remain inconclusive. To support targeted care, we provide a comprehensive overview of the prevalence and severity of FCR among cancer survivors and patients, as measured using the short form of the validated Fear of Cancer Recurrence Inventory (FCRI‐SF). We also report on associations between FCR and clinical and demographic characteristics.Methods: This is a systematic review and individual participant data (IPD) meta‐analysis on the prevalence of FCR. In the review, we included all studies that used the FCRI‐SF with adult (≥18 years) cancer survivors and patients. Date of search: 7 February 2020. Risk of bias was assessed using the Joanna Briggs Institute critical appraisal tool.Results: IPD were requested from 87 unique studies and provided for 46 studies comprising 11,226 participants from 13 countries. 9311 respondents were included for the main analyses. On the FCRI‐SF (range 0–36), 58.8% of respondents scored ≥13, 45.1% scored ≥16 and 19.2% scored ≥22. FCR decreased with age and women reported more FCR than men. FCR was found across cancer types and continents and for all time periods since cancer diagnosis.Conclusions: FCR affects a considerable number of cancer survivors and patients. It is therefore important that healthcare providers discuss this issue with their patients and provide treatment when needed. Further research is needed to investigate how best to prevent and treat FCR and to identify other factors associated with FCR.The protocol was prospectively registered (PROSPERO CRD42020142185).

11 November 2016 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Open access
MKMalene Korsholm
Malene Korsholm
OMOle Mogensen
Ole Mogensen
MJMette M. Jeppesen
Mette M. Jeppesen
VLVibeke K. Lysdal
Vibeke K. Lysdal
KTKoen Traen
Koen Traen
PJPernille Tine Jensen
Pernille Tine Jensen
Background: Same‐day discharge has been suggested to safe and acceptable following minimally invasive hysterectomy.Objectives: To evaluate the feasibility of same‐day discharge following minimally invasive hysterectomy and to identify associated factors.Search strategy: Medline, Embase and the Cochrane Central Register of Controlled Trials were systematically searched using the terms “same day discharge”, “minimally invasive surgery”, and “hysterectomy” between October 1 and October 31, 2015. No language or publication date restrictions were included.Selection criteria: Randomized controlled trials and observational studies evaluating same‐day discharge before midnight on the day of minimally invasive hysterectomy were included.Data collection and analysis: Study characteristics, pre‐operative selection criteria, and predictive factors for same‐day discharge were analyzed.Main results: There were 15 observational studies with 11 992 patients included. Significant heterogeneity was observed in the studies, and publication and selection bias could have potentially affected the results. All the studies concluded that same‐day discharge was feasible. However, some factors were associated with a decreased possibility of same‐day discharge; these were older age, beginning surgery later than 1:00 pm and completing surgery later than 6:00 pm, longer duration of operation, and high estimated blood loss.Conclusions: Same‐day discharge appears feasible for a majority of patients who undergo minimally invasive hysterectomies if adequate emphasis is placed on pre‐surgical planning and careful patient selection.

1 December 2016 in European Journal of Cancer
Verified
Journal Article
Closed access
MJMette Moustgaard Jeppesen
Mette Moustgaard Jeppesen
PJPernille Tine Jensen
Pernille Tine Jensen
DHDorte Gilså Hansen
Dorte Gilså Hansen
MIMaria Iachina
Maria Iachina
OMOle Mogensen
Ole Mogensen

6 July 2018 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
MJM M Jeppesen
M M Jeppesen
PJP T Jensen
P T Jensen
DHD G Hansen
D G Hansen
RCR D Christensen
R D Christensen
OMO Mogensen
O Mogensen

30 June 2015 in Journal of Psychosomatic Obstetrics & Gynecology
Verified
Journal Article
Closed access
MJMette Moustgaard Jeppesen
Mette Moustgaard Jeppesen
OMOle Mogensen
Ole Mogensen
PDPernille Dehn
Pernille Dehn
PJPernille Tine Jensen
Pernille Tine Jensen
Introduction: Rehabilitation after cancer is important, and efficient rehabilitation requires knowledge of patient’s needs. This study aimed to identify short-term rehabilitation needs of women with endometrial and cervical cancer. Methods: Ninety-six women (82.6%) were included in an exploratory questionnaire study from Odense University Hospital from September 2011 to March 2012. Needs were assessed pre-treatment and 3 months later using the three-levels-of-needs questionnaire. Furthermore, 16 women participated in focus group interviews following the treatment. The interviews were audio-recorded, transcribed verbatim and analyzed thematically. Results: Forty-four of the included women were diagnosed with cervical cancer (median age 45 years). Of these, 22 had FIGO-stage 1 disease (50%) and 23 received radiation therapy (52.3%). The remaining 52 women (median age 66.5 years) were diagnosed with endometrial cancer. Of these, 38 had FIGO-stage 1 disease (73.1%) and 25 were treated with laparoscop...

12 January 2017 in Acta Oncologica
Verified
Journal Article
Closed access
MJMette Moustgaard Jeppesen
Mette Moustgaard Jeppesen
OMOle Mogensen
Ole Mogensen
DHDorte Gilså Hansen
Dorte Gilså Hansen
MIMaria Iachina
Maria Iachina
MKMalene Korsholm
Malene Korsholm
PJPernille Tine Jensen
Pernille Tine Jensen
Background: Considerable controversy remains as to the optimal organization of endometrial cancer follow-up. Aim: To evaluate the relationship between the way recurrence was detected and survival after treatment for endometrial cancer. Further, to identify characteristics associated with a pre-scheduled examination in women with symptomatic recurrence. Material and methods: All women with early stage endometrial cancer during 2005–2009 were included in a population-based historical cohort derived from the Danish Gynecological Cancer Database. Women diagnosed with recurrence within three years after primary surgery and the mode of recurrence detection were identified from hospital charts: asymptomatic recurrence detected at regular follow-up, symptomatic recurrence detected at regular follow-up or symptomatic recurrence detected in between follow-up. Survival of women with symptomatic and asymptomatic disease was compared. Furthermore, characteristics associated with self-referral as compared to presenting symptoms at regular follow-ups were identified using univariate analyses. Results: In total, 183 cases of recurrence (7%) were identified in the cohort of 2612 women. Of these, 65.5% were symptomatic with vaginal bleeding as the most prevalent symptom. Asymptomatic women had a significantly better three-year survival rate compared to symptomatic women (80.3% vs. 54.3%, p < 0.01). A total of 2.3% of the entire population had an asymptomatic recurrence. Women diagnosed at a pre-scheduled visit due to symptoms had a higher educational level (p = 0.03) and more often high-risk disease (p = 0.02) than symptomatic women diagnosed at regular follow-up. Conclusion: Early stage endometrial cancer carries a low risk of recurrence. Survival appears to be superior in asymptomatic patients, but length-time bias, i.e. the effect of aggressive tumor biology in symptomatic recurrences, may bias results in non-randomized controlled trials. Well educated patients with symptoms of recurrence more often sought medical attendance compared to less educated counterparts. This should be considered if patient-initiated follow-up is the standard care.